Main > A1. CORP. INDEX. Fn-Fz > Fresenius AG./P C2 > Fresenius Kabi/P C2
Fresenius Kabi/P C2's subsections
2007. 12.29.2007. Blood Substitute
2008. 09.10.2008. Corp. Acq.
2010. 11.11.2010. BI
2012. 08.09.2012. Onco.>Colon C.
2012. 10.01.2012. Acetylcysteine
2012. 12.14.2012. Corp. Acq.
2013. 08.19. PT Soho Global Health
2014. 08.26. PN>Kabiven &
2017. 04.24. Acq. Akorn & Merck
2018. 12.10. fish oil triglycerides
2019. 06.20. Dexmedetomidine.HCl
2019. 07.08. Levothyroxine Na Inj
2019. 08.30. Phenylephrine.HCl Inj.
2019. 10.07. Fulvestrant Inj. 250mg
2019. 11.13. Fosaprepitant for Inj.
2019. 12.11. Anti-Infective Ertapen
2020. 02.05. Diab.>Hypoglycemia
2022. 03.14. USA FDA 510(k) Clearan
2022. 05.04. Acq. Ivenix Inc.
Web-Site
Z - OK
Fresenius Kabi/P C2's products
This section has no products